Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
PHARMA - GENEPHARM AUSTRALIAN DISTRIBUTION PACT

Genepharm in pact with 3 Australian distributors

 

BY OUR PHARMA  CORRESPONDENT

15 July, 2005: Genepharm Australasia has finalised agreements with three pharmacy wholesalers to distribute generics to pharmacies across Australia, the company said in an official release.

The agreement has been made with Australian Pharmaceutical Industries, Mayne Group and Sigma, and will lead to sales and distribution arrangements with every pharmacy in the country. With the conclusion of these agreements and earlier agreements with hospital distributors, it now has access to the whole Australian retail and hospital markets for its product supplies. The company expects to begin distributing generic pharmaceuticals to the retail pharmacy and hospital markets in early 2006.

Genepharm plans to release around 18 new generic pharmaceuticals to the market in 2006, including versions of the top five selling generics which had a combined market of nearly A$900 million (US$665.6 million) in 2004, the release said.

Genepharm Australasia is a specialist generic pharmaceutical company listed on the Australian Stock Exchange and it develops, markets and distributes a range of generic pharmaceuticals, including some of the newest and highest value Pharmaceutical Benefits Scheme (PBS) pharmaceuticals.

MORE CORPORATE NEWS
Deals and pacts, mergers and acquisitions, lawsuits etc

Second trial on Merck’s painkiller Vioxx begins
17 September, 2005

Impax delisted from Nasdaq

39 drug firms sued over price rigging in California

Chiron rebuffs Novartis' bid

Nasdaq delists Able on bankruptcy filing

Some of the Vioxx suits may be settled: Merck

Glaxo Smithkline in pact with IAVI to develop AIDS drug

Pfizer acquires Vicuron Pharma for $1.9 billion

Ranbaxy acquires generic product portfolio from Efarmes

Novasite Pharma buys PsyCheNomicS

Temasek sets up $112 million pharma JV

Able Laboratories files bankruptcy suit with US court

Cardiac Science-Defibtech lawsuit settled

Par loses ondansetron case to GSK

Florida sues Mylan, Teva and Watson

Lupin in pact with Kyowa of Japan

British Pharma seeks opinion on industry code

European biotech start-ups fail to win late-stage funds

Afghan’s first generics plant to go on stream by Oct. ‘05

Merck sets up generic arm Genpharm in US

Novo Nordisk, Eli Lilly remove insulin products from Australia

Glaxo inks co-promotion pact with Eisai for Paritec

Elder Pharma plans unit, brand acquisition

Nectar Lifesciences plans Rs 90 crore IPO

Genepharm in pact with 3 Australian distributors 

Novartis acquires Bristol-Myers’ OTC business in US

Novartis completes Eon Labs buy

Orbus inks supply pact with Docpharma 

Novartis acquires rights of kidney dialysis drug from SeBo

Nektar buys out Aerogen for $32 m

BioVeris licenses Baxter's vaccine portfolio

Carl Icahn sells Mylan shares

Dey and Connecticut settle pricing dispute

   Pharma Home

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us